Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP211035.RA-Vk2hNRPbO9fbquONxD2rlaIMs4PIpVLt3Zs55FcOws130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211035.RA-Vk2hNRPbO9fbquONxD2rlaIMs4PIpVLt3Zs55FcOws130_provenance.
• NP612683.RAlZE6QHzbmsHmGJzEzIiqXc1L7sT_EyoJHfMRsr92syA130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612683.RAlZE6QHzbmsHmGJzEzIiqXc1L7sT_EyoJHfMRsr92syA130_provenance.
• assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP538953.RAWfR1nNb7Te8S4rqpVCtDYNB75XMTC5KB80KMVLI1Su4130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538953.RAWfR1nNb7Te8S4rqpVCtDYNB75XMTC5KB80KMVLI1Su4130_provenance.
• NP538954.RAfEgt1TrjqNvbixVsCWP2zjJEjmMplhO3QUAyzQjAeYg130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538954.RAfEgt1TrjqNvbixVsCWP2zjJEjmMplhO3QUAyzQjAeYg130_provenance.
• NP538952.RAiraxtMX8p1ceycLhBPWmMgdrtbv1N95SypR1R-iGICE130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP538952.RAiraxtMX8p1ceycLhBPWmMgdrtbv1N95SypR1R-iGICE130_provenance.
• NP330041.RA6xxaSaZg-Bd4836tKpMMWfqWiJvoqF-nAbjJSnNXv8s130_assertion description "[Silencing of NFkappaB1 by small interfering RNA abrogated the capacity of RA bone marrow CD34+ cells to differentiate into fibroblast-like cells and to produce MMP-1 and vascular endothelial growth factor upon stimulation with stem cell factor, granulocyte-macrophage colony stimulating factor and TNF-alpha without influencing their viability and capacity to produce beta2-microglobulin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330041.RA6xxaSaZg-Bd4836tKpMMWfqWiJvoqF-nAbjJSnNXv8s130_provenance.